With a robust background in venture capital, the fund manager has executed over 30 investments primarily in the biotechnology and healthcare sectors. Active across North America and Europe, their strategic approach emphasizes an operator-first philosophy, fostering close relationships with portfolio companies. Notable exits include several successful IPOs and acquisitions, showcasing their expertise in guiding startups from early-stage investments through to growth phases. This experience reflects a commitment to data-driven decision-making, ensuring thorough analysis at every stage of the investment process.